NovaBridge Biosciences ( NBP) - Stock Earnings
NBP Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Aug. 19, 2026, midnight | — / — | — | — / — | — |
NBP Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q3 | -6.8 million USD | 238.0 million USD |
| 2025Q4 | -30.8 million USD | — USD |
| 2026Q1 | -4.4 million USD | — USD |
| 2026Q3 Est. | — | — |
| 2026Q4 Est. | — | — |
NBP Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -1.5 billion USD | 4.5 million USD |
| 2024 | -162.3 million USD | — USD |
| 2025 | -6.6 million USD | — USD |
| 2026 Est. | — | — |
NBP
Price: $2
52 week price:
Earnings Per Share: -0.49 USD
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 190.8 million